This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aufdemorte, T. B.
Right arrow Articles by Beck, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aufdemorte, T. B.
Right arrow Articles by Beck, L. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 74, Issue 8 1153-1161, Copyright © 1992 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

An intraosseous device for studies of bone-healing. The effect of transforming growth-factor beta

TB Aufdemorte, WC Fox, GR Holt, HS McGuff, AJ Ammann and LS Beck
University of Texas Health Science Center, San Antonio 78284-7750.

A novel implantable device, the analytic bone implant, was used in order to establish a model for studies of bone-healing and the evaluation of factors that augment the process, such as transforming growth-factor beta (TGF-beta). This device was implanted into the tibiae of four baboons. After healing, bone was removed from the center chamber. Recombinant human TGF beta-1 was then delivered to the core of the device. After twenty-two days of healing, the device was disassembled and the newly formed bone was removed from the core of the implant for histomorphometric analysis. An analysis of the bone revealed a substantial effect of TGF-beta on osteoblastic activity and proliferation compared with that seen in control and placebo groups. However, despite increased osteoblastic activity, trabecular bone volumes at twenty-two days were equivalent among the groups. The number of osteoclasts and the erosion of the surface were also increased, although not significantly so. Substantial endochondral formation of bone was seen in the supraperiosteal tissues directly over the implants that contained TGF-beta but not over the implants in the control and placebo groups. These data demonstrate the utility of this bone-implant model for studies of bone-healing with minimally invasive methods. In addition, use of the device provided the first in vivo data on the effects of TGF-beta at an intermediate (twenty-two-day) time-point in the healing process in a non-human primate.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
J. F. Quinlan, R. W. G. Watson, G. Kelly, P. M. Kelly, J. M. O'Byrne, and J. M. Fitzpatrick
Transforming growth factor-beta (TGF-{beta}) in acute injuries of the spinal cord
J Bone Joint Surg Br, March 1, 2006; 88-B(3): 406 - 410.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul
Transforming Growth Factor-{beta}1 to the Bone
Endocr. Rev., October 1, 2005; 26(6): 743 - 774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. D. Dinbergs, L. Brown, and E. R. Edelman
Cellular Response to Transforming Growth Factor-beta 1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions
J. Biol. Chem., November 22, 1996; 271(47): 29822 - 29829.
[Abstract] [Full Text] [PDF]